SW
SkyOak Wealth’s Lineage Cell Therapeutics LCTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Hold |
15,000
| – | – | ﹤0.01% | 243 |
|
|
2025
Q1 | $6.77K | Hold |
15,000
| – | – | ﹤0.01% | 242 |
|
|
2024
Q4 | $7.54K | Hold |
15,000
| – | – | ﹤0.01% | 253 |
|
|
2024
Q3 | $13.6K | Hold |
15,000
| – | – | ﹤0.01% | 239 |
|
|
2024
Q2 | $15K | Hold |
15,000
| – | – | ﹤0.01% | 240 |
|
|
2024
Q1 | $22.2K | Hold |
15,000
| – | – | 0.01% | 243 |
|
|
2023
Q4 | $16.4K | Hold |
15,000
| – | – | ﹤0.01% | 236 |
|
|
2023
Q3 | $17.7K | Hold |
15,000
| – | – | 0.01% | 233 |
|
|
2023
Q2 | $21.2K | Hold |
15,000
| – | – | 0.01% | 239 |
|
|
2023
Q1 | $22.5K | Hold |
15,000
| – | – | 0.01% | 249 |
|
|
2022
Q4 | $17.6K | Hold |
15,000
| – | – | 0.01% | 226 |
|
|
2022
Q3 | $17K | Hold |
15,000
| – | – | 0.01% | 216 |
|
|
2022
Q2 | $24K | Hold |
15,000
| – | – | 0.01% | 219 |
|
|
2022
Q1 | $23K | Hold |
15,000
| – | – | 0.01% | 239 |
|
|
2021
Q4 | $37K | Hold |
15,000
| – | – | 0.01% | 244 |
|
|
2021
Q3 | $38K | Hold |
15,000
| – | – | 0.01% | 230 |
|
|
2021
Q2 | $43K | Hold |
15,000
| – | – | 0.01% | 235 |
|
|
2021
Q1 | $40K | Hold |
15,000
| – | – | 0.01% | 233 |
|
|
2020
Q4 | $26K | Hold |
15,000
| – | – | 0.01% | 215 |
|
|
2020
Q3 | $14K | Hold |
15,000
| – | – | 0.01% | 204 |
|
|
2020
Q2 | $13K | Hold |
15,000
| – | – | ﹤0.01% | 237 |
|
|
2020
Q1 | $12K | Hold |
15,000
| – | – | 0.01% | 210 |
|
|
2019
Q4 | $13K | Buy |
+15,000
| New | +$13K | ﹤0.01% | 307 |
|